We review here findings for the CCL2-CCR2 and CCL3-CCR5 chemokine-receptor systems that show the effects of these molecules on T cell differentiation. Possible roles of other chemokines and G ...
Summary: Maraviroc is the first CCR5 coreceptor antagonist to receive marketing approval from the Food and Drug Administration (FDA) for the treatment of CCR5-tropic human immunodeficiency virus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback